Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation

Massimo Martino^{1

2}, Mercedes Gori³, Gaetana Porto^{4

5}, Maria Pellicano⁵, Ludovica Santoro^{4

5}, Chiara Verduci^{4

5}, Filippo Antonio Canale^{4

5}, Barbara Loteta^{4

5}, Tiziana Moscato^{4

5}, Caterina Alati⁶, Maria Consuelo Ieracitano⁷, Amelia Cuzzocrea⁷, Maria Altomonte⁷, Maria Teresa Florenzano⁷, Antonella Morabito⁷, Giuseppe Irrera^{4

5}, Virginia Naso^{4

5}, Marta Pugliese^{4

5}, Giuseppe Console^{4

5}, Anna Ferreri^{4

5}, Lucrezia Imbalzano^{4

5}, Giovanni Tripepi⁸, Annalisa Pitino³

Affiliations

¹ Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Department of Hemato‑Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli,", 89124, Reggio Calabria, Italy. dr.massimomartino@gmail.com.
² Stem Cell Transplant Program CIC587, 89124, Reggio Calabria, Italy. dr.massimomartino@gmail.com.
³ Institute of Clinical Physiology (IFC-CNR), Section of Rome, 00185, Rome, Italy.
⁴ Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Department of Hemato‑Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli,", 89124, Reggio Calabria, Italy.
⁵ Stem Cell Transplant Program CIC587, 89124, Reggio Calabria, Italy.
⁶ Hematology Unit, Department of Hemato‑Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianch I-Melacrino-Morelli,", 89124, Reggio Calabria, Italy.
⁷ Pharmacy Unit, Department of Hemato‑Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianch I-Melacrino-Morelli,", 89124, Reggio Calabria, Italy.
⁸ Institute of Clinical Physiology (IFC-CNR), Section of Reggio Calabria, 89124, Reggio Calabria, Italy.

Published Erratum

Massimo Martino et al. Ann Hematol. 2023 Aug.

. 2023 Aug;102(8):2297-2298.

doi: 10.1007/s00277-023-05323-1.

¹ Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Department of Hemato‑Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli,", 89124, Reggio Calabria, Italy. dr.massimomartino@gmail.com.
² Stem Cell Transplant Program CIC587, 89124, Reggio Calabria, Italy. dr.massimomartino@gmail.com.
³ Institute of Clinical Physiology (IFC-CNR), Section of Rome, 00185, Rome, Italy.
⁴ Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Department of Hemato‑Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli,", 89124, Reggio Calabria, Italy.
⁵ Stem Cell Transplant Program CIC587, 89124, Reggio Calabria, Italy.
⁶ Hematology Unit, Department of Hemato‑Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianch I-Melacrino-Morelli,", 89124, Reggio Calabria, Italy.
⁷ Pharmacy Unit, Department of Hemato‑Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianch I-Melacrino-Morelli,", 89124, Reggio Calabria, Italy.
⁸ Institute of Clinical Physiology (IFC-CNR), Section of Reggio Calabria, 89124, Reggio Calabria, Italy.

No abstract available

Erratum for

Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation.
Martino M, Gori M, Porto G, Pellicano M, Santoro L, Verduci C, Canale FA, Loteta B, Moscato T, Alati C, Ieracitano MC, Cuzzocrea A, Altomonte M, Florenzano MT, Morabito A, Irrera G, Naso V, Pugliese M, Console G, Ferreri A, Imbalzano L, Tripepi G, Pitino A. Martino M, et al. Ann Hematol. 2023 Jul;102(7):1915-1925. doi: 10.1007/s00277-023-05228-z. Epub 2023 Apr 20. Ann Hematol. 2023. PMID: 37079070 Free PMC article.